ProBiotix Health Expands in North America After Partnership with...

Pharma Tech Outlook: Pharma Tech Magazine

ProBiotix Health Expands in North America After Partnership with Genuine Health

By Pharma Tech Outlook | Thursday, January 21, 2021

Stephen Patrick O'Hara, CEO

OptiBiotix Health PLC announces ongoing commercial activities in North America on its subsidiary, ProBiotix Health.

FREMONT, CA: OptiBiotix Health PLC (OptiBiotix), a life sciences corporation that develops compounds to fight obesity, high cholesterol, and diabetes, is pleased to announce ongoing commercial activities in North America on its subsidiary, ProBiotix Health (ProBiotix).

ProBiotix has issued the non-exclusive license agreement for LPLDL to produce a cardiovascular health product in Canada and the USA to Genuine Health Inc (Genuine Health). Genuine Health is a prominent natural health business in Canada that for over 25 years has been structuring natural goods.

Mikkel Hvid-Hansen, Commercial Director at ProBiotix, commented: "We are pleased to have signed an agreement with Genuine Health in such an important market for probiotic products. We believe working with the Canadian company creates a unique opportunity to achieve a probiotic health claim for cardiovascular health, while providing further product differentiation in the North American market."

In order to present cardiovascular and other health statements, Genuine Health entirely promotes products containing LPLDL. Genuine Health will send its goods to Health Canada, a government agency of Canada responsible for the country's federal health policy, as part of the agreement. LPLDL will be the first probiotic supplement on the Canadian market to earn a particular health claim for cardiovascular health if registration is successful.

Stewart Brown, Founder and CEO at Genuine Health, commented: "We are excited to work towards introducing innovative and science-backed products into the North American market through our relationship with ProBiotix. As such, we look forward to a long and successful partnership with ProBiotix Health."

The new agreement follows a range of essential licensing contracts announced earlier this year for the company-wide North American market. These agreements allow the company to further expand its brand and product recognition in a strong, rising marketplace and position itself by leveraging the microbiome as a leader in improving health and well-being.

Weekly Brief

Read Also